-
公开(公告)号:EP3757200B1
公开(公告)日:2024-10-30
申请号:EP20190972.8
申请日:2016-08-19
-
公开(公告)号:EP3683242B1
公开(公告)日:2024-10-30
申请号:EP18855240.0
申请日:2018-09-11
发明人: ISHIKAWA Kotaro , KASHIWAMURA Takuro , KATO Takuya , KOGA Toru , ISHIKAWA Suguru
IPC分类号: A61K8/73 , A61K31/737 , A61P17/16 , A61Q19/00 , C08B37/00
-
公开(公告)号:EP3453751B1
公开(公告)日:2024-10-23
申请号:EP18202909.0
申请日:2012-05-31
IPC分类号: C11D3/43 , C11D3/20 , C11D7/50 , C11D7/26 , C09D11/326 , C09D11/328 , A01N25/02 , C09D7/20
-
-
公开(公告)号:EP4277967B1
公开(公告)日:2024-09-25
申请号:EP22702348.8
申请日:2022-01-07
CPC分类号: C10G2300/20720130101 , C10G29/20 , C10G29/04
-
公开(公告)号:EP4431105A1
公开(公告)日:2024-09-18
申请号:EP22892849.5
申请日:2022-11-10
发明人: KUNO, Hitoshi , KANNO, Akiko , KOMATSU, Satoko , KAMETANI, Yoshie , OHSHIMA, Shino , OHNO, Yusuke
IPC分类号: A61K36/05 , A23K10/30 , A23L33/10 , A61K8/9722 , A61P37/04 , A61P43/00 , A61Q19/00 , C12N1/12
CPC分类号: A23K10/30 , A23L33/10 , A61K8/9722 , A61K36/05 , A61P37/04 , A61P43/00 , A61Q19/00 , C12N1/12
摘要: It is an object of the present invention to provide a means capable of appropriately regulating differentiation of T cells, in order to avoid overactivation of T cells after stimulation of the T cells with superantigens or the like and the subsequent decrease in the immune functions (exhaustion of the immune system). The present invention relates to a T cell differentiation-regulating agent, comprising, as an active ingredient, an algal body of microalgae belonging to the genus Coccomyxa, a dry powder thereof, or an extract thereof.
-
-
8.
公开(公告)号:EP4414037A2
公开(公告)日:2024-08-14
申请号:EP24165019.1
申请日:2017-09-15
发明人: NAGASE, Hiroshi , FUJII, Hideaki , SAITOH, Akiyoshi , NAKATA, Eriko , HIROSE, Masaaki , OOI, Isao , HAYASHIDA, Kohei
IPC分类号: A61P43/00
CPC分类号: A61K31/439 , A61K31/444 , A61K31/4709 , A61K31/497 , A61K31/501 , A61K31/506 , A61P25/24 , A61P25/04 , A61P21/00 , A61P25/22 , A61P25/06 , A61P43/00 , A61K31/485
摘要: The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exhibits an opioid δ receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid δ receptor-related diseases (for example, a depression as a symptom associated with Alzheimer's disease) can be treated or prevented.
-
公开(公告)号:EP3585738B1
公开(公告)日:2024-08-14
申请号:EP18713742.7
申请日:2018-02-26
IPC分类号: C02F1/76 , C01B11/02 , C02F103/02
-
-
-
-
-
-
-
-
-